| [1] Meir Steiner, Edward Dunn, Leslie Born. Hormones and mood: from menarche to menopause and beyond[J]. J Affect Disord, 2003, 74(1):67-83.[2] Berecki-Gisolf J, Begum N, Dobson A J. Symptoms reported by women in midlife: menopausal transition or aging? [J] Menopause, 2009, 16(5):1021-1029.[3] Susan E Gilbert Evans, Lori E Ross, Edward M Sellers, et al. 3alpha-reduced neuroactive steroids and their precursors during pregnancy and the postpartum period[J]. Gynecol Endocrinol, 2005, 21(5):268-279.[4] Mehta D, Newport D J, Frishman G, et al. Early predictive biomarkers for postpartum depression point to a role for estrogen receptor signaling[J]. J Psychological medicine, 2014, 5: 1-14.[5] Marie K Osterlund, Michael Robin Witt, Jan-Ake Gustafsson. Estrogen action in mood and neurodegenerative disorders: estrogenic compounds with selective properties-the next generation of therapeutics[J]. Endocrine, 2005, 28(3):235-242.[6] Andrea J Rapkin, Judith A Mikacich, Babak Moatakef-Imani, et al. The clinical nature and formal diagnosis of premenstrual, postpartum, and peri-menopausal affective disorders[J]. Curr Psychiatry Rep, 2002, 4(6):419-428.[7] Jessica Zonana, Jack M Gorman. The neurobiology of postpartum depression[J]. CNS Spectr, 2000, 10(10):792-799, 805.[8] Lasiuk G C, Hegadoren K M. The effects of estradiol on central serotonergic systems and its relationship to mood in women[J]. Biol Res Nurs, 2007, 9(2):147-60.[9] Barbara L Parry, Charles J Meliska, L Fernando Martinez, et al. Menopause: neuroendocrine changes and hormone replacement therapy[J]. J Am Med Womens Assoc, 2004, 59(2):135-145.[10] Grady D, Gebretsadik T, Kerlikowske K, et al. Hormone replacement therapy and endometrial cancer risk: a meta-analysis[J]. Obstet Gynecol, 1995, 85(2):304-313.[11]Song Q W, Wang X G. Progress in research on PE for prevention and treatment of perimenopausal syndrome[J]. Foreign Medical Science (Section of Maternal and Child Health), 2004, 15:124-125.[12] Charlotta Dabrosin, Chen Jian-min, Wang Linda, et al. Flaxseed inhibits metastasis and decreases extracellular vascular endothelial growth factor in human breast cancer xenografts[J]. Cancer Lett, 2002, 185(1):31-37.[13] Franziska Kramer Birkved, Alicja Mortensen, Jose L Peñalvo, et al. Investigation into the cancer protective effect of flaxseed in Tg. NK (MMTV/c-neu) mice, a murine mammary tumor model[J]. Genes Nutr, 2011, 6(4):403-411.[14] Yasin Tülüce, Halil Ozkol, Ismail Koyuncu. Photoprotective effect of flax seed oil (Linumusitatissimum L.) against ultraviolet C-induced apoptosis and oxidative stress in rats[J]. ToxicolInd Health, 2012, 28(2):99-107.[15] Wang Ying-feng, Xu Zhi-kun, Yang Dong-hui, et al. The antidepressant effect of secoisolariciresinol, a lignan-type phytoestrogen constituent of flaxseed, on ovariectomizedmice[J]. J Nat Med, 2013, 67(1):222-227.[16] Ronald S Duman, George K Aghajanian. Neurobiology of Rapid Acting Antidepressants: Role of BDNF and GSK-3β[J]. J Neuropsychopharmacology, 2014, 39(1): 233-233[17] Joanna L Spencer-Segal, Elizabeth M Waters, Kevin G Bath, et al. Distribution of phosphorylated TrkB receptor in the mouse hippocampal formation depends on sex and estrous cycle stage[J]. J Neurosci, 2011, 31(18):6780-6790.[18] Tadahiro Numakawa, Misty Richards, Shingo Nakajima, et al. The role of brain-derived neurotrophic factor in comorbid depression: possible linkage with steroid hormones, cytokines, and nutrition[J]. J Frontiers in psychiatry, 2014, 5:136.[19] Helen E Scharfman, Thomas C Mercurio, Jeffrey H Goodman, et al. Hippocampal excitability increases during the estrous cycle in the rat: a potential role for brain-derived neurotrophic factor[J]. J Neurosci, 2003, 23(37):11641-11652.[20] Alicia A Walf, Cheryl A Frye. Antianxiety and antidepressive behavior produced by physiological estradiol regimen may be modulated by hypothalamic-pituitary-adrenal axis activity[J]. J Neuropsychopharmacology, 2005, 30(7):1288-1301.[21] Naoko Bekku, Hiroyuki Yoshimura. Animal model of menopausal depressive-like state in female mice: prolongation of immobility time in the forced swimming test following ovariectomy[J]. Psychopharmacology (Berl), 2005, 183(3):300-307.[22] Lucien Steru, Raymond Chermat, Bernard Thierry, et al. The tail suspension test: a new method for screening antidepressants in mice[J]. Psychopharmacology (Berl), 1985, 85(3):367-370.[23] Porsolt R D, Le Pichon M, Jalfre M. Depression: a new animal model sensitive to antidepressant treatments[J]. Nature, 1977, 266(5604):730-732.[24] Xu Ying, Ku Bao-shan, Yao Hai-yan, et al. The effects of curcumin on depressive-like behaviors in mice[J]. Eur J Pharmacol, 2005, 518(1):40-46.[25] Vivien K Burt, Kira Stein. Epidemiology of depression throughout the female life cycle[J]. J Clin Psychiatry, 2002, 63 (Suppl 7):9-15.[26] Ronald C Kessler. Epidemiology of women and depression[J]. J Affect Disord, 2003, 74(1):5-13.[27] Miki Bloch, Robert C Daly, David R Rubinow. Endocrine factors in the etiology of postpartum depression[J]. Compr Psychiatry, 2003, 44(3):234-246.[28] Heidi D Nelson, Linda L Humphrey, Peggy Nygren, et al. Postmenopausal hormone replacement therapy: scientific review[J]. JAMA, 2002, 288(7):872-881.[29] Valerie Beral, Million Women Study Collaborators, Bull D, et al. Ovarian cancer and hormone replacement therapy in the Million Women Study[J]. Lancet, 2007, 369:1703-1710.[30] Amnon Brzezinski, Ayelet Debi. Phytoestrogens: the "natural" selective estrogen receptor modulators? [J]. Eur J Obstet Gynecol Reprod Biol, 1999, 85(1):47-51.[31] Ayman A Ewies. Phytoestrogens in the management of the menopause: up-to-date[J]. Obstet Gynecol Surv, 2002, 57(5):306-313.[32] Susan R Sturgeon, Stella L Volpe, Elaine Puleo, et al. Effect of flaxseed consumption on urinary levels of estrogen metabolites in postmenopausal women[J]. Nutr Cancer, 2010, 62(2):175-180.[33] Helena M Barros, Maristela Ferigolo. Ethopharmacology of imipramine in the forced-swimming test: gender differences[J]. Neurosci Biobehav Rev, 1998, 23:279-286.[34] Benoit Petit-Demouliere, Franck Chenu, Michel Bourin. Forced swimming test in mice: a review of anti-depressant activity[J]. Psychopharmacology (Berl), 2005, 177(3):245-255. [35] Naoko Bekku, Hiroyuki Yoshimura, Hiroaki Araki. Factors producing a menopausal depressive-like state in mice following ovariectomy[J]. Psychopharmacology (Berl), 2006, 187(2):170-180.[36]Bekku N, Yoshimura H. Animal model of menopausal depressive-like state in female mice: prolongation of immobility time in the forced swimming test following ovariectomy[J]. Psychopharmacology (Berl), 2005,183:300-307.[37] Liisa A Galea, Jennifer K Wide, Alasdair M Barr. Estradiol alleviates depressive-like symptoms in a novel animal model of post-partum depression[J]. Behav Brain Res, 2001, 122(1):1-9.[38] Erin C Stoffel, Rebecca M Craft. Ovarian hormone withdrawal-induced "depression" in female rats[J]. Physiol Behav, 2004, 83(3):505-513.[39] Joanna L Spencer-Segal, Elizabeth M Waters, Kevin G Bath, et al. Distribution of phosphorylated TrkB receptor in the mouse hippocampal formation depends on sex and estrous cycle stage[J]. J Neurosci, 2011, 31(18):6780-6790.[40] Helen E Scharfman, Thomas C Mercurio, Jeffrey H Goodman, et al. Hippocampal excitability increases during the estrous cycle in the rat: a potential role for brain-derived neurotrophic factor[J]. J Neurosci, 2003, 23(37):11641-11652.[41] Clive R Bramham, Debabrata Panja. BDNF regulation of synaptic structure, function, and plasticity[J]. J Neuropharmacology, 2014, 76(Pt: C): 601-602.[42] Kaoru Sato, Tatsuhiro Akaishi, Norio Matsuki, et al. beta-Estradiol induces synaptogenesis in the hippocampus by enhancing brain-derived neurotrophic factor release from dentate gyrus granule cells[J]. Brain Res, 2007, 1150:108-120.[43] Helen E Scharfman, Tana M Hintz, Juan Gomez, et al. Changes in hippocampal function of ovariectomized rats after sequential low doses of estradiol to simulate the preovulatory estrogen surge[J]. Eur J Neurosci, 2007, 26(9):2595-2612.[44] Melinda K Jezierski, Farida Sohrabji. Estrogen enhances retrograde transport of brain-derived neurotrophic factor in the rodent forebrain[J]. Endocrinology, 2003, 144(11):5022-5029.[45] Carol J Haggans, Elsa J Travelli, William Thomas, et al. The effect of flaxseed and wheat bran consumption on urinary estrogen metabolites in premenopausal women[J]. Cancer Epidemiol Biomarkers Prev, 2000, 9(7):719-725.[46] Charlotte Carreau, Gilles Flouriot, Catherine Bennetau-Pelissero, et al. Enterodiol and enterolactone, two major diet-derived polyphenol metabolites have different impact on ER alpha transcriptional activation in human breast cancer cells[J]. J Steroid Biochem Mol Biol, 2008, 110(1-2): 176-185.[47] Kenji Hashimoto. Brain-derived neurotrophic factor (BDNF) and its precursor pro-BDNF as diagnostic biomarkers for major depressive disorder and bipolar disorder[J]. J European archives of psychiatry and clinical neuroscience, 2015(1): 83-84.[48] Zhang Qi, Liu Gang, Wu Yi, et al. BDNF promotes EGF-induced proliferation and migration of human fetal neural stem/progenitor cells via the PI3K/Akt pathway[J]. Molecules, 2011, 16(12):10146-10156. |
